Platelet Rich Plasma (PRP) treatment is now available at Spire Cambridge Lea Hospital

30 June 2014

Spire Cambridge Lea Hospital is now offering Platelet Rich Plasma (PRP) treatment for patients suffering with Tennis or Golfer’s elbow.

Platelet Rich Plasma (PRP) treatment is now available at Spire Cambridge Lea Hospital with Mr Niel Kang, consultant orthopaedic surgeon. PRP is currently being used as an alternative treatment method for orthopaedic conditions which have traditionally required surgery or other extensive treatments.


PRP treatment involves a small amount of blood being taken from the patient. The blood is then placed in a centrifuge which spins and separates the platelets from the rest of the blood. The patient’s own platelets are then collected into a highly concentrated formula which is injected directly into the injured area.  When platelets become activated, growth factors are released and initiate the body’s natural healing response; tendon regeneration can be achieved by injecting platelet-rich plasma into the degenerative tendon.

PRP is a relatively new treatment used for some orthopaedic conditions such as:

  • Tennis elbow
  • Golfer’s elbow

To find out more about this service or to arrange a consultation please call us on 01223 266929 or email

About Mr Niel Kang

Mr Niel Kang is a specialist upper limb surgeon with expertise in shoulder, elbow, and complex upper limb trauma surgery, and non-surgical treatments for upper limb soft tissue conditions (tendinopathies). Keyhole (arthroscopic) surgery and joint replacement form a core component of his service. 

Niel Kang has numerous peer reviewed publications and national presentations. His current research focuses on the non-surgical treatment of shoulder and elbow soft tissue degenerative diseases. 


Event Booking Form


Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.